Harriet L Mills1, Edward White, Caroline Colijn, Peter Vickerman, Robert Heimer. 1. Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, United Kingdom. Electronic address: harriet.l.mills@gmail.com.
Abstract
BACKGROUND: HIV infection is prevalent among drug injectors in St. Petersburg and their non-injecting heterosexual partners (PIDUs). There are fears that sexual transmission of HIV from IDUs to PIDUs may portend a self-sustaining, heterosexual epidemic in Russia. METHODS: Our model combines a network model of sexual partnerships of IDUs and non-IDUs to represent sexual transmission of HIV and a deterministic model for parenteral transmission among IDUs. Behavioural parameters were obtained from a survey of St. Petersburg IDUs and their sexual partners. We based our model fits on two scenarios for PIDU prevalence in 2006 (5.6% and 15.1%, calculated excluding and including HCV co-infected PIDUs respectively) and compared predictions for the general population HIV prevalence. RESULTS: Results indicate that sexual transmission could sustain a non-IDU HIV epidemic. The model indicates that general population prevalence may be greater than current estimates imply. Parenteral transmission drives the epidemic and the PIDU bridge population plays a crucial role transferring infection to non-IDUs. The model indicates that the high PIDU prevalence is improbable because of the high risk behaviour this implies; the lower prevalence is possible. CONCLUSION: The model implies that transmission through PIDUs will sustain a heterosexual epidemic, if prevalence among IDUs and PIDUs is as high as survey data suggest. We postulate that current estimates of population prevalence underestimate the extent of the HIV epidemic because they are based on the number of registered cases only. Curtailing transmission among injectors and PIDUs will be vital in controlling heterosexual transmission.
BACKGROUND:HIV infection is prevalent among drug injectors in St. Petersburg and their non-injecting heterosexual partners (PIDUs). There are fears that sexual transmission of HIV from IDUs to PIDUs may portend a self-sustaining, heterosexual epidemic in Russia. METHODS: Our model combines a network model of sexual partnerships of IDUs and non-IDUs to represent sexual transmission of HIV and a deterministic model for parenteral transmission among IDUs. Behavioural parameters were obtained from a survey of St. Petersburg IDUs and their sexual partners. We based our model fits on two scenarios for PIDU prevalence in 2006 (5.6% and 15.1%, calculated excluding and including HCV co-infected PIDUs respectively) and compared predictions for the general population HIV prevalence. RESULTS: Results indicate that sexual transmission could sustain a non-IDU HIV epidemic. The model indicates that general population prevalence may be greater than current estimates imply. Parenteral transmission drives the epidemic and the PIDU bridge population plays a crucial role transferring infection to non-IDUs. The model indicates that the high PIDU prevalence is improbable because of the high risk behaviour this implies; the lower prevalence is possible. CONCLUSION: The model implies that transmission through PIDUs will sustain a heterosexual epidemic, if prevalence among IDUs and PIDUs is as high as survey data suggest. We postulate that current estimates of population prevalence underestimate the extent of the HIV epidemic because they are based on the number of registered cases only. Curtailing transmission among injectors and PIDUs will be vital in controlling heterosexual transmission.
Authors: Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn Journal: J Infect Dis Date: 2005-03-30 Impact factor: 5.226
Authors: Evgeny M Krupitsky; Edwin E Zvartau; Dimitry V Masalov; Marina V Tsoy; Andrey M Burakov; Valentina Y Egorova; Tatyana Y Didenko; Tatyana N Romanova; Eva B Ivanova; Anton Y Bespalov; Elena V Verbitskaya; Nikolai G Neznanov; Alexandr Y Grinenko; Charles P O'Brien; George E Woody Journal: J Subst Abuse Treat Date: 2006-07-24
Authors: Elisa F Long; Margaret L Brandeau; Cristina M Galvin; Tatyana Vinichenko; Swati P Tole; Adam Schwartz; Gillian D Sanders; Douglas K Owens Journal: AIDS Date: 2006-11-14 Impact factor: 4.177
Authors: Alla V Shaboltas; Olga V Toussova; Irving F Hoffman; Robert Heimer; Sergei V Verevochkin; Robert W Ryder; Kaveh Khoshnood; Tom Perdue; Benoit R Masse; Andrei P Kozlov Journal: J Acquir Immune Defic Syndr Date: 2006-04-15 Impact factor: 3.731
Authors: Nadia Abdala; John M Carney; Amanda J Durante; Nikolai Klimov; Dimitri Ostrovski; Anton M Somlai; Andrei Kozlov; Robert Heimer Journal: Int J STD AIDS Date: 2003-10 Impact factor: 1.359
Authors: Sarah K Calabrese; Sara E Burke; John F Dovidio; Olga S Levina; Anneli Uusküla; Linda M Niccolai; Robert Heimer Journal: AIDS Behav Date: 2016-01
Authors: Elena Dukhovlinova; Alexey Masharsky; Olga Toussova; Sergei Verevochkin; Tatiana Solovyeva; Maria Meringof; Elijah Paintsil; Edward White; Russell Barbour; Robert Heimer; Andrei Kozlov Journal: AIDS Res Hum Retroviruses Date: 2015-01-05 Impact factor: 2.205
Authors: Zoe Ward; Jack Stone; Chrissy Bishop; Viktor Ivakin; Ksenia Eritsyan; Anna Deryabina; Andrea Low; Javier Cepeda; Sherrie L Kelly; Robert Heimer; Robert Cook; Frederick L Altice; Taylor Litz; Assel Terlikbayeva; Nabila El-Bassel; Denis Havarkov; Alena Fisenka; Anelia Boshnakova; Andrey Klepikov; Tetiana Saliuk; Tetiana Deshko; Peter Vickerman Journal: Lancet HIV Date: 2021-12-09 Impact factor: 12.767
Authors: Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper Journal: Ann Epidemiol Date: 2014-01-24 Impact factor: 3.797
Authors: Jeffrey H Samet; Anita Raj; Debbie M Cheng; Elena Blokhina; Carly Bridden; Christine E Chaisson; Alexander Y Walley; Tibor P Palfai; Emily K Quinn; Edwin Zvartau; Dmitry Lioznov; Evgeny Krupitsky Journal: Addiction Date: 2014-10-16 Impact factor: 6.526
Authors: Javier A Cepeda; Ksenia Eritsyan; Peter Vickerman; Alexandra Lyubimova; Marina Shegay; Veronika Odinokova; Leo Beletsky; Annick Borquez; Matthew Hickman; Chris Beyrer; Natasha K Martin Journal: Lancet HIV Date: 2018-07-20 Impact factor: 12.767
Authors: Angelos Hatzakis; Vana Sypsa; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Katerina Micha; Anastasios Panopoulos; Meni Malliori; Mina Psichogiou; Anastasia Pharris; Lucas Wiessing; Marita van de Laar; Martin Donoghoe; Douglas D Heckathorn; Samuel R Friedman; Don C Des Jarlais Journal: Addiction Date: 2015-07-14 Impact factor: 6.526
Authors: Meghan Bellerose; Lin Zhu; Liesl M Hagan; William W Thompson; Liisa M Randall; Yelena Malyuta; Joshua A Salomon; Benjamin P Linas Journal: Int J Drug Policy Date: 2019-11-15